Skip to main content

Global Reprocessed Medical Devices Market Size, Emerging Trends, Growth Drivers, Future Outlook and Forecasts Opportunities 2022: Credence Research

According to the latest report published by Credence Research, Inc. “Reprocessed Medical Devices Market – (Device Type – Cardiovascular Medical Devices, Orthopedic Medical Devices, Gastroenterology Medical Devices, General Surgery Medical Devices, and Laparoscopic Surgery Medical Devices): Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the  market was valued at USD 1,079.1 Mn in 2015, and is expected to reach USD 2,461.4 Mn by 2022, expanding at a CAGR of 10.6% from 2016 to 2022.
Browse the full report Reprocessed Medical Devices: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at http://www.credenceresearch.com/report/reprocessed-medical-devices-market
Market Insights:
Increasing pressure to reduce medical waste on medical organization due to environmental concerns are the major factors driving the global reprocessed medical devices market. North America held the largest regional market, accounting for the market share of over 50% in 2015, and is expected to dominate the global reprocessed medical devices market during the forecast period of 2016 to 2022. Rising pressure of managing hospital expenditure among hospital authorities and reduced pricing and improved quality of reprocessed medical devices are the factors driving the reprocessed medical devices market in the region. Asia Pacific is expected to grow at a highest growth rate during the focus period, due to developing healthcare infrastructure, and reduction in the cost of the medical device which is driving the market in Asia Pacific.
Among the device types, cardiovascular medical devices are the dominating segment in terms of revenue due to its rising incorporation in the cardiac surgeries which is rising worldwide. Devices such as cardiac positioning and stabilization devices, electrophysiology catheters and blood pressure cuffs are the widely used reprocessed medical devices. The electrophysiology catheters held the largest share in the cardiovascular medical device segment. Laparoscopy segment held the second largest share of the market due to the rising demand for minimally invasive techniques, thus presenting opportunities for more reprocessing approvals, spearheading the growth for the laparoscopic segment during the forecast period.
Chapter 1 Preface        
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology
Chapter 2 Executive Summary
2.1 Global Reprocessed Medical Devices Market Portaiture
2.2 Global Reprocessed Medical Devices Market, by Device, 2015 (USD Mn)
2.3 Reprocessed Medical Devices Market Share, by Geography, 2015 (Value %)
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290

Comments

Popular posts from this blog

Home Healthcare Market has Positive Long-Term Growth Outlook 2017-2023: Credence Research

Credence Research has recently issued a new market assessment report titled “Home Healthcare – Growth, Future Prospects and Competitive Analysis, 2016 – 2023”. The global Home Healthcare Market study provides a comprehensive view of the ongoing and future phases of the Home Healthcare industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution. Browse the report at  http://www.credenceresearch.com/report/home-healthcare-market Based on geographic/regional distribution the global Home Healthcare Market is studied for key regional markets focusing on the respective geographic trends and statistics, and thereby delivering market size and forecast values. The Home Healthcare Market based on geographic classification is studied for North America, Europe, Asia-Pacific, Latin America, and...

Rheumatoid Arthritis Therapeutics Market Assessment Report Now Available at Credence Research

Credence Research has recently issued a new market assessment report titled “ Rheumatoid Arthritis Therapeutics  – Growth, Future Prospects and Competitive Analysis, 2016 – 2024”. The global Rheumatoid Arthritis Therapeutics Market study provides a comprehensive view of the ongoing and future phases of the Rheumatoid Arthritis Therapeutics industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution. Browse the report at  http://www.credenceresearch.com/report/rheumatoid-arthritis-therapeutics-market Based on geographic/regional distribution the global Rheumatoid Arthritis Therapeutics Market is studied for key regional markets focusing on the respective geographic trends and statistics, and thereby delivering market size and forecast values. The Rheumatoid Arthritis Therapeutics Market based on geogra...

Global Liquid Biopsy Market Dynamics, Forecast, Analysis and Supply Demand 2022: Credence Research

According to the latest report published by Credence Research, Inc. “ Liquid Biopsy Market   Growth, Future Prospects and Competitive Analysis, 2016-2022,” the liquid biopsy market was valued at USD 1,881.9 Mn in 2015, and is expected to reach USD 10,850.3 Mn by 2022, expanding at a CAGR of 24.7% from 2016 to 2022. Browse the full report Liquid Biopsy: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at  http://www.credenceresearch.com/report/liquid-biopsy-market Market Insights In the past, tissue samples extracted through biopsy were evaluated to detected malignancy. However, some micrographs delivered inconsistent and ambiguous results, thus demanding repeated procedure. The advent of molecular diagnostics and next generation sequencing offered pathologists with a powerful tool for efficient diagnosis. Even with such advances, cancer diagnosis still remained subject to the limitation of availability of biopsied tissue, which fu...